Tate & Lyle invests in enzyme immobilisation platform Zymtronix
date:Feb 06, 2020
ingredients to help deliver just that.

Improving lives for generations is at the heart of what we do, so we are excited to harness the power of Zymtronixs enzyme immobilisation platform, which will make our manufacturing processes more efficient.

The platform also has the potential to accelerate our ability to make our ingredient solutions accessible to more consumers.

Zymtronix has designed its enzyme immobilisation platform to transform ingredient manufacturing by improving the productivit
2/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/26 03:27